Prospective Cohort of Patients With Newly Diagnosed Glioblastoma: Analysis of MMP2 and MMP9 Expression and Correlation to Neuro-imaging Features. (MM-Predict)
Sponsor: Assistance Publique Hopitaux De Marseille
A NA clinical study on Brain Tumor, this trial is actively recruiting participants. The trial is conducted by Assistance Publique Hopitaux De Marseille and has accumulated 8 data snapshots since 2018. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
8 versions recorded-
Feb 2026 — Present [monthly]
Recruiting NA
-
Sep 2024 — Feb 2026 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Apr 2024 — Jul 2024 [monthly]
Recruiting NA
Status: Unknown Status → Recruiting
-
Jun 2022 — Apr 2024 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
▶ Show 3 earlier versions
-
Jan 2021 — Jun 2022 [monthly]
Recruiting NA
-
Aug 2018 — Jan 2021 [monthly]
Recruiting NA
-
Jun 2018 — Aug 2018 [monthly]
Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Assistance Publique Hopitaux De Marseille
For direct contact, visit the study record on ClinicalTrials.gov .